![Vasily Fedorin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vasily Fedorin
Directeur des opérations chez
4BIO Ventures Management Ltd.
Profil
Vasily Fedorin is currently the Chief Operating Officer at 4BIO Ventures Management Ltd. He previously worked as a Marketing Manager at MS WESTFALIA GmbH from 2009 to 2010.
Dr. Fedorin holds a doctorate degree from Lomonosov Moscow State University Business School, which was conferred in 2008.
Postes actifs de Vasily Fedorin
| Sociétés | Poste | Début |
|---|---|---|
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. Investment ManagersFinance 4bio Ventures invest in companies located in the United Kingdom. The firm targets the companies operating in the fields of gene therapy, cell theray, RNA based therapy, targeted therapies and microbiome. They provide financing for early stage capital requirements. | Directeur des opérations | 01/03/2022 |
Anciens postes connus de Vasily Fedorin
| Sociétés | Poste | Fin |
|---|---|---|
MS WESTFALIA GmbH
 MS WESTFALIA GmbH Medical DistributorsDistribution Services Distributes medical equipment | Private Equity Investor | 01/02/2010 |
Formation de Vasily Fedorin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
MS WESTFALIA GmbH
MS WESTFALIA GmbH Medical DistributorsDistribution Services Distributes medical equipment | Distribution Services |
Lomonosov Moscow State University Business School
 Lomonosov Moscow State University Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. Investment ManagersFinance 4bio Ventures invest in companies located in the United Kingdom. The firm targets the companies operating in the fields of gene therapy, cell theray, RNA based therapy, targeted therapies and microbiome. They provide financing for early stage capital requirements. | Finance |
